A phase IIb trial of BIO 201 in patients with dry age related macular degeneration
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2017
At a glance
- Drugs BIO 201 (Primary)
- Indications Dry age-related macular degeneration
- Focus Therapeutic Use
- Acronyms MACA; MACA-INT
- 19 Jul 2017 According to a Biophytis media release, results from this trial are expected in 2H 2021.
- 15 Jun 2017 According to a Biophytis media release, this study will be initiated in second half of 2018.
- 07 Jul 2016 New trial record